AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Value investing focuses on finding undervalued assets for higher returns. Learn effective strategies to enhance your investment portfolio.
26,852 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
As SpaceX IPO chatter grows, investors seek breadth over a single-name bet. A diversified space ETF offers exposure t...
SpaceX has captured headlines with a blockbuster IPO, but the stock has cooled. This article breaks down how historic...
As earnings season kicks off, public comments surge over the SEC's bid to allow semiannual reporting. ExxonMobil's CF...
Bitcoin could test lower levels as bearish theses grow louder. This report outlines ticking risk factors, potential p...
Windermere Real Estate has tapped Diana Wall to lead growth across its independent brokerage network, underscoring a ...
Pi Network marks its first anniversary since the Open Network launch. Upgrades and exchange listings signal progress,...
Tiny changes can add up fast. This guide shares 16 practical steps you can start today to boost savings, cut debt, an...
U.S. Customs announced a 45-day, no-lawsuits refund program for tariffs, aiming to speed refunds to importers and red...
Honda is recalibrating its EV plan amid slower demand, while REV Group seals a Terex acquisition, creating a pivotal ...
A wave of AI-generated wedding memes and rumors grabbed headlines, but the real lesson isn’t about celebrity gossip—i...
CFTC staff released a new FAQ detailing how crypto assets can be used as collateral for derivatives, including specif...